NEWARK, Calif., April 9, 2013 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by StemCells, Inc. (Nasdaq:STEM), please note that in the first paragraph of the release, the pro forma cash balance date should be December 31, 2012, not December 31, 2013. All other data was correct.
CONTACT: Rodney Young StemCells, Inc. Chief Financial Officer (510) 456-4128 Ian Stone Russo Partners (619) 308-6541
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts